Sexual Dimorphism in Adverse Pregnancy Outcomes - A Retrospective Australian Population Study 1981-2011

Abstract

ObjectivesSexual inequality starts in utero. The contribution of biological sex to the developmental origins of health and disease is increasingly recognized. The aim of this study was to assess and interpret sexual dimorphisms for three major adverse pregnancy outcomes which affect the health of the neonate, child and potentially adult.MethodsRetrospective population-based study of 574,358 South Australian singleton live births during 1981–2011. The incidence of three major adverse pregnancy outcomes [preterm birth (PTB), pregnancy induced hypertensive disorders (PIHD) and gestational diabetes mellitus (GDM)] in relation to fetal sex was compared according to traditional and fetus-at-risk (FAR) approaches.ResultsThe traditional approach showed male predominance for PTB [20–24 weeks: Relative Risk (RR) M/F 1.351, 95%-CI 1.274–1.445], spontaneous PTB [25–29 weeks: RR M/F 1.118, 95%-CI 1.044–1.197%], GDM [RR M/F 1.042, 95%-CI 1.011–1.074], overall PIHD [RR M/F 1.053, 95%-CI 1.034–1.072] and PIHD with term birth [RR M/F 1.074, 95%-CI 1.044–1.105]. The FAR approach showed that males were at increased risk for PTB [20–24 weeks: RR M/F 1.273, 95%-CI 1.087–1.490], for spontaneous PTB [25–29 weeks: RR M/F 1.269, 95%-CI 1.143–1.410] and PIHD with term birth [RR M/F 1.074, 95%-CI 1.044–1.105%]. The traditional approach demonstrated female predominance for iatrogenic PTB [25–29 weeks: RR M/F 0.857, 95%-CI 0.780–0.941] and PIHD associated with PTB [25–29 weeks: RR M/F 0.686, 95%-CI 0.581–0.811]. The FAR approach showed that females were at increased risk for PIHD with PTB [25–29 weeks: RR M/F 0.779, 95%-CI 0.648–0.937].ConclusionsThis study confirms the presence of sexual dimorphisms and presents a coherent framework based on two analytical approaches to assess and interpret the sexual dimorphisms for major adverse pregnancy outcomes. The mechanisms by which these occur remain elusive, but sex differences in placental gene expression and function are likely to play a key role. Further research on sex differences in placental function and maternal adaptation to pregnancy is required to delineate the causal molecular mechanisms in sex-specific pregnancy outcome. Identifying these mechanisms may inform fetal sex specific tailored antenatal and neonatal care.

miRNAs Differentially Expressed by Next-Generation Sequencing in Cord Blood Buffy Coat Samples of Boys and Girls

“…Furthermore, Cordero et al identified 117 miRNAs present in buffy coat samples, which were differentially methylated between men and women [90], some of which overlap with the cord blood miRNAs identified in our study. It is possible that differences in oxidative stress, inflammation, growth and birth outcomes observed between newborn boys and girls [91][92][93] could be controlled, at least in part, by differentially expressed miRNAs. Age is another host factor that can bias epigenetic markers [94,95].…”

The Spectrum of Adverse Pregnancy Outcomes Based on Kidney Disease Diagnoses: A 20-Year Population Study

“…In addition, the large number of births in this cohort available for assessment adds to the study strength, enabling identification of over 1,300 women with kidney disorders, and with disease subgroups in sufficient numbers for novel comparative analysis. The POU database has previously been extensively utilized as a research database providing high-quality population-level data [32][33][34]; however, the limitations of diagnostic coding data are acknowledged. ICD-9 codes rather than ICD-10 are captured in this dataset.…”

Abruptio placentae risk and genetic variations in mitochondrial biogenesis and oxidative phosphorylation: replication of a candidate gene association study

“…In addition, we examined the extent to which the association of wGRS with AP risk is modified by known and potential risk factors of AP: preeclampsia, 32 advanced maternal age, 33 and infant sex. 34 These analyses could have important clinical and public health implications by highlighting potential gene-gene or gene-environment interactions, enhancing the biologic understanding of the mechanisms that lead to AP, and facilitating therapeutic efforts to reduce impact of AP. 35 …”